603259 药明康德
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)7.72018.89020.71814.36111.887
总资产报酬率 ROA (%)5.72713.88714.71210.0527.839
投入资产回报率 ROIC (%)6.54716.07417.20911.6869.067

边际利润分析
销售毛利率 (%)39.36641.17937.29636.28537.992
营业利润率 (%)29.45629.43027.06726.36320.498
息税前利润/营业总收入 (%)25.78928.49226.35126.63323.520
净利润/营业总收入 (%)24.83024.04622.62122.42518.060

收益指标分析
经营活动净收益/利润总额(%)99.75798.31289.97571.94477.377
价值变动净收益/利润总额(%)-1.5291.6579.02220.99319.544
营业外收支净额/利润总额(%)-0.572-0.341-0.318-0.368-0.597

偿债能力分析
流动比率 (X)2.2172.0621.6551.6932.911
速动比率 (X)1.8341.7411.2641.2382.572
资产负债率 (%)25.94524.64027.46029.69529.320
带息债务/全部投入资本 (%)12.4649.43711.85911.73010.263
股东权益/带息债务 (%)668.575914.681705.652701.827782.145
股东权益/负债合计 (%)283.454303.673262.277235.136239.406
利息保障倍数 (X)-7.371-33.994-41.82272.5447.482

营运能力分析
应收账款周转天数 (天)80.99161.90648.44765.11071.860
存货周转天数 (天)85.81878.92884.420105.97177.741